BioNTech SE (BNTX) Short term Debt (2018 - 2026)

BioNTech SE has reported Short term Debt for 8 years, with the latest figure at $1.1 billion in Q4 2025.

• Quarterly Short term Debt fell 46.45% year-over-year to $1.1 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 billion (down 46.45% YoY) and the FY2025 annual result came in at $1.1 billion, down 48.02% from the prior year.
• Short term Debt grew to $1.1 billion in Q4 2025 per BNTX's latest filing, from $698.4 million in the prior quarter.
• Over five years, Short term Debt peaked at $2.0 billion in Q4 2024 and troughed at $157.2 million in Q2 2024.
• A 5-year average of $676.0 million and a median of $467.1 million in 2023 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2021 and 2023: Short term Debt jumped 1441.37% in 2021, then sank 78.19% in 2023.
• Over 5 years, Short term Debt stood at $1.4 billion in 2021, then tumbled by 41.18% to $801.0 million in 2022, then plunged by 44.23% to $446.7 million in 2023, then jumped by 356.78% to $2.0 billion in 2024, then tumbled by 46.45% to $1.1 billion in 2025.
• According to Business Quant data, Short term Debt over the past three periods registered $1.1 billion, $698.4 million, and $164.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.